The proposed bill establishes a new section, 381.992, in the Florida Statutes, which focuses on individualized investigational treatments for patients with life-threatening or severely debilitating illnesses. It defines key terms such as "eligible facility," "eligible patient," and "individualized investigational treatment," and outlines the criteria that patients must meet to qualify for such treatments. The bill authorizes eligible facilities and manufacturers to provide these treatments and allows patients to request them. It also permits health plans, third-party administrators, and governmental agencies to cover the costs associated with these investigational drugs, biological products, or devices, while limiting liability for healthcare providers involved in the treatment process.

Additionally, the bill includes provisions to protect healthcare providers from disciplinary actions related to their recommendations for individualized investigational treatments. It prohibits any state officials from obstructing a patient's access to these treatments and ensures that patients are informed about the potential risks and costs associated with their use. Importantly, the bill states that if a patient dies while receiving such treatment, their heirs will not be liable for any related debts. The act is set to take effect on July 1, 2025.